CompletedNCT01104792
What is this study about?This study evaluated the long-term safety of Cariprazine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–60
- Countries
- United States, Colombia, India, + 3 others
- Sponsor
- Forest Laboratories
CompletedNCT00790192
What is this study about?Researchers compared Lurasidone, Quetiapine XR and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–75
- Countries
- United States, India, Romania, + 2 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT00789698
What is this study about?Researchers compared Lurasidone HC1 and Quetiapine XR to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–75
- Countries
- United States, Colombia, India, + 3 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT00615433
What is this study about?This study evaluated the safety and effectiveness of Lurasidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–75
- Countries
- United States, Colombia, India, + 2 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT01821378
What is this study about?This study evaluated the safety and effectiveness of Lurasidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–75
- Countries
- United States, Colombia, Romania, + 3 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT03376763
What is this study about?Researchers studied Abilify maintena to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including GongjuSchizophreniaMedication studyAges 19–64
- Countries
- South Korea
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
CompletedNCT00350805
Official study titleRelating the 'Experienced Present' With the Mechanisms of Neuronal Function: A Comparative Study in Patients With Schizophrenia and Healthy Controls Using Psychophysical and Neurophysiological Methods
This study has finished and is no longer accepting participants.
Multiple locations, including CréteilSchizophreniaObservational studyAges 18–50
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
CompletedNCT01391390
Official study titleThe Effect of Melatonin Treatment on Tardive Dyskinesia and Oxidative Stress: A Double-Blind Placebo-Controlled Trial
This study has finished and is no longer accepting participants.
In BeijingSchizophreniaMedication studyAges 18–70
- Countries
- China
- Sponsor
- Beijing HuiLongGuan Hospital
CompletedNCT00757978
Official study titlePhase 4 Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms in Patients Using Clozapine. A Randomized, Double-Blind, Placebo Controled Study
This study has finished and is no longer accepting participants.
In Porto AlegreSchizophreniaMedication studyAges 18–60
- Countries
- Brazil
- Sponsor
- Hospital de Clinicas de Porto Alegre